Preferred Label : Therapeutic Prostate Cancer Peptide Vaccine TENDU;
NCIt synonyms : TENDU; TET-based Prostate Cancer Peptide Vaccine TENDU; TENDU Vaccine; Tetanus-epitope-targeting-based Prostate Cancer Peptide Vaccine TENDU;
NCIt definition : A peptide cancer vaccine, based on the tetanus-epitope targeting (TET)-platform, composed
of as of yet undisclosed tumor-associated antigens (TAAs) that are specific for prostate
cancer and a tetanus-based vaccine adjuvant in the same molecule, with potential immunomodulating
and antineoplastic activities. Upon administration, therapeutic prostate cancer peptide
vaccine TENDU may stimulate a potent cytotoxic T-lymphocyte (CTL) immune response
against prostate cancer cells that express these TAAs, resulting in tumor cell lysis.
The tetanus peptide may enhance the anti-tumor immune response.;
NCI Metathesaurus CUI : CL1662423;
Origin ID : C179644;
UMLS CUI : C5555838;
Semantic type(s)
- concept_is_in_subset
